ArticleInternational journal of nanomedicine2017

Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia.

Xiaoyan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.